GLOBUS MEDICAL, INC. Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities
GLOBUS MEDICAL, INC. (GMED) reported Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities of 3.62 million shares for the 9-month period ending 2023-09-30, per its 10-Q filed 2024-11-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities · last filed 2024-11-05
- 2023-09-30: Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 9 month 3.62M shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 9 month |
|---|---|
| 2023-09-30 | 3.62M shares 10-Q · filed 2024-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |